Clinical trial
A Randomized, Double-blind, Active-controlled, Multicenter Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Concomitant Mometasone Furoate and Levocabastine HCl in Perennial Allergic Rhinitis Patients
NCT02498509 is registered in ClinicalTrials.gov with Chong Kun Dang Pharmaceutical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-blind, Active-controlled, Multicenter Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Concomitant Mometasone Furoate and Levocabastine HCl in Perennial Allergic Rhinitis Patients
- Lead sponsor
- Chong Kun Dang Pharmaceutical
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 31, 2015
- Completion date
- May 31, 2016
- Enrollment
- 459 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.